Chapter 5

Valuation

At about $142, Accenture trades near 10 times forward earnings — its lowest multiple in over a decade, and the cheapest in its own peer group despite the highest returns in it. Two independent methods say the same thing: on a normal discount rate, a no-growth perpetuity of today's free cash flow is worth more than the current price, so the market has priced Accenture's cash generation to shrink, not merely to stall. Consensus disagrees, with a mean target 26% higher.

From premium to discount

For most of the last decade Accenture was a premium compounder, and the market paid for it: a P/E that peaked near 37 times in 2021 and averaged in the mid-20s over ten years. A $100 stake in the Class A shares at the end of fiscal 2020 comfortably outran both the S&P 500 and its technology sub-index through fiscal 2025 [3]. In 2026 that premium disappeared. The shares fell more than half over the year, with the sharpest single-day drop on June 18, 2026 after the fiscal-third-quarter results paired a cut to full-year growth guidance with a large cybersecurity acquisition.

Sources: peak and ten-year-average P/E are market data (approximate); the July 2026 figure is $142.14 divided by FY2025 diluted EPS of $12.15 [1].

The de-rating is not explained by the reported numbers, which barely moved. FY2025 delivered $69.7 billion of revenue, diluted EPS of $12.15, and $10.9 billion of free cash flow at 1.4 times net income [1] [2]. What changed was the multiple placed on those numbers — the compression is an expectations story, and this chapter is about what those expectations now are.

What today's price pays for

At $142.14 (July 7, 2026) against 632 million diluted shares, the equity is worth roughly $90 billion; net of about $6.3 billion of net cash, the enterprise is around $84 billion [1] [6]. On that base the buyer collects a high cash yield.

Sources: P/E from price $142.14 over FY2025 diluted EPS $12.15 and consensus FY2026 EPS ~$13.86; FCF yield from FY2025 free cash flow $10.9B over ~$90B equity value; dividend yield from the $1.63 quarterly rate annualized [1] [2] [4]; price and consensus per market data as of July 7, 2026.

The forward earnings yield is about 9.7%, the free-cash-flow yield roughly 12%, and the dividend — raised 10% to $1.63 a quarter for fiscal 2026 — yields about 4.6% [4]. Those are yields normally attached to businesses expected to shrink. Accenture is not shrinking: it earns a 24.6% return on equity and converts about $1.30 of free cash for every dollar of net income, with fiscal 2026 free-cash-flow guidance of $10.8–11.5 billion, roughly flat on the prior year [5]. The tension between an elite return profile and a distressed-looking yield is the substance of the valuation.

Where it sits against peers

Accenture is the largest company in its sector by two to three times and earns the highest return on equity in it (the margin and scale benchmarks are in Competitive Moat). It now trades at the bottom of the multiple table — roughly level with Capgemini, which earns single-digit net margins, and well below the Indian majors that out-earn it on margin.

Source: trailing P/E, market data as of approximately July 2026; Accenture computed from price $142.14 over FY2025 diluted EPS $12.15 [1].

The whole group has de-rated on the same AI-deflation fear (the industry-wide revenue compression is documented in Competitive Moat), so a low absolute multiple is not Accenture-specific. What is specific is the ranking: the sector's scale and returns leader is priced at or below rivals with structurally lower profitability. Either the market expects Accenture's returns to converge down toward the group, or the relative pricing is inconsistent with the relative quality. That is the disagreement a buyer is taking a side of.

What the multiple implies for growth

A cleaner way to read the price is to solve for the growth it embeds. Discount fiscal 2026 free cash flow of about $11 billion as a growing perpetuity at a cost of equity, and ask what perpetual growth rate reproduces today's ~$90 billion equity value. At a 9% cost of equity the answer is roughly negative 3% — the price is consistent with free cash flow that declines a few percent a year, indefinitely.

Source: derived from FY2026 free-cash-flow guidance midpoint (~$11.15B) [5]; current equity value ~$90B from price $142.14 over 632M diluted shares [1].

Read the chart the other way: hold growth at zero, and a perpetuity of current free cash flow is worth more than the market pays at any cost of equity up to about 12%. At 9–10% it is worth 24–38% more. Only if a buyer demands a 12%-plus return does a no-growth Accenture look fairly priced today; below that, the price already bakes in decline.

The single assumption this rests on is the discount rate. A higher cost of equity — justified if AI genuinely raises the risk to the earnings stream — narrows the gap and can close it near 12%. The reverse-DCF is therefore not proof the stock is cheap; it is a precise statement of the bet. Paying $142 is a wager that Accenture's free cash flow does no worse than flat. The through-line question — tailwind or deflation — is, in valuation terms, exactly that: whether the billable base holds.

The gap to consensus, and what would change the read

The sell-side has not followed the price down to a decline scenario. The mean analyst target sits near $179, about 26% above the current quote, and the rating distribution remains skewed to buy and hold rather than sell. A buyer at today's price is thus paid two ways to wait: the ~4.6% dividend, backed by a $7.9 billion repurchase authorization [7], and the gap to consensus fair value if growth merely stabilizes.

The strongest fact against reading the multiple as a mispricing is that it is not resting on nothing. Growth genuinely decelerated, fiscal 2026 guidance was cut, and near-term EPS estimates have been revised down far more often than up in recent weeks — the same AI-deflation mechanism that shows up in peers' results (Competitive Moat) is a real, not imagined, headwind. A market pricing negative perpetual growth is early and aggressive, but it is extrapolating a trend that is visible in the numbers, not inventing one.

What would decide it is observable and cheap to monitor: whether free cash flow holds near the guided ~$11 billion or begins to erode; whether the advanced-AI and non-FTE revenue lines (Advanced AI Economics) scale fast enough to offset core deceleration; and whether book-to-bill recovers above 1.0. If cash generation stays flat to growing, the reverse-DCF says the price is discounting a decline that is not happening. If it starts to fall, the multiple was an early read rather than an overreaction. The valuation does not settle the through-line — it prices one side of it, and hands the reader a small set of numbers that will.